Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **ocular surface tissues** comprise the anatomical and functional unit covering the anterior eye, primarily including the corneal and conjunctival epithelia, goblet cells, lacrimal and meibomian glands, eyelids, eyelashes, and the tear film[1][3][6]. This unit protects the eye from desiccation, pathogens, and mechanical damage, and enables clear vision by maintaining a smooth, refractive corneal surface. A sophisticated interplay of secretory (tears) and structural components (epithelia, glands, blink mechanisms) is critical to surface health and immune regulation[6][8]. Pathology involves complex disturbance across these tissues, and therapies target restoration of function or integrity at the tissue level, not at a single molecular entity.
null (see above; mechanisms relate to enhancement of lubrication, facilitation of healing, immunomodulation, anti-infective action, etc.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular surface tissues.